Pressemeddelelse 23. februar 2010

 

Abbott Announces 10 Percent Increase in Quarterly Dividend

 

Nyeste pressemeddelelser


01-09-2010
Abbott Receives FDA Approval for First Automated Molecular Test for Assessing Hepatitis B Treatment
DES PLAINES, Ill., Sept. 1, 2010 — Abbott announced today it...
30-08-2010
Abbott to Present at Morgan Stanley Global Healthcare Unplugged Conference
ABBOTT PARK, Ill., Aug. 30, 2010 – Abbott will present at th...
28-07-2010
Abbott's SIMCOR® (niacin extended-release / simvastatin) Receives FDA Approval for New Dosage Strengths
ABBOTT PARK, Ill., July 28, 2010 – Abbott today received U.S...
28-07-2010
Abbott Fund-Sponsored Laboratory Training Initiative Helps Stem Critical Shortage of Medical Professionals in California
ANAHEIM, Calif., July 28, 2010 — Imagine needing a critical ...
26-07-2010
Abbott to Feature Novel Tests and New Upgrades to Testing Platforms at American Association for Clinical Chemistry Lab Expo
ANAHEIM, Calif., July 26, 2010 – A first-of-its-kind test th...

Ønsker du mere viden om Abbott eller har du spørgsmål, er du velkommen til at kontakte: Communication Advisor Danek Olsen:

 

Danek Olsen Communication Advisor

 

Telefon: +45 3977 0034

Fax: +45 3977 0199

E-mail: danek.olsen@abbott.com

 

Company Declares 345 Consecutive Quarterly Dividend

 

 Press release as pdf file

 


ABBOTT PARK, Ill., Feb. 19, 2010 — The board of directors of Abbott today increased the company's quarterly common dividend 10 percent to 44 cents per share.


This marks the 38th consecutive year that Abbott has increased its dividend payout and the 345th consecutive quarterly dividend to be paid by Abbott since 1924. The cash dividend is payable May 15, 2010, to shareholders of record at the close of business on April 15, 2010.


Abbott was recently named by Money as a leading dividend stock. Additionally, Abbott is a top performer of theS&P 500 Dividend Aristocrats Index, which tracks companies that have annually increased their dividend for 25 consecutive years.

 

About Abbott
Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs approximately 83,000 people and markets its products in more than 130 countries.


Abbott's news releases and other information are available on the company's Web site at www.abbott.com.